Peter Gassner took cloud software into life sciences: how Veeva built a specialised platform

Peter Gassner founded Veeva Systems in 2007 after senior roles at Salesforce and other enterprise-software companies.

Veeva focused narrowly on cloud applications for pharmaceutical and life-sciences companies rather than building generic CRM for every industry.

What followed was not a straight expansion into every adjacent market. Veeva Systems moved through specific technical and commercial turning points that gradually changed what customers expected from it.

CRM proved vertical cloud software could scale

Veeva built its first major product on Salesforce’s platform, adapting customer-relationship management to regulatory and workflow requirements specific to pharmaceutical sales teams.

This shift also changed how customers consumed the technology. Instead of treating software or infrastructure as a one-off purchase, the relationship became more continuous, with updates, capacity and services delivered over time.

Vault moved the company onto its own content-and-data platform

Veeva developed Vault for regulated content, clinical, quality and regulatory processes, reducing dependence on Salesforce and broadening its role across the drug-development lifecycle.

This was an important turning point because it expanded what Veeva Systems could offer or the markets it could address. The effect becomes clearer when viewed as part of the longer sequence of changes that followed.

The 2013 IPO brought vertical SaaS into the spotlight

Veeva went public in 2013 after rapid growth in a specialised market that had previously relied heavily on customised enterprise systems.

For Veeva Systems, access to public markets was more than a branding milestone. It increased financial transparency and created another route to fund expansion, acquisitions or long-term product development.

Public-benefit status formalised a long-term operating philosophy

Veeva converted to a public benefit corporation in 2021, adding a formal stakeholder purpose alongside its for-profit obligations.

This was an important turning point because it expanded what Veeva Systems could offer or the markets it could address. The effect becomes clearer when viewed as part of the longer sequence of changes that followed.

Specialisation became the moat

As of 18 September 2026, veeva now provides cloud software, data and services across life sciences. The company’s history demonstrates the economics of vertical SaaS: deep knowledge of one regulated industry can be more defensible than a broad product serving every customer type.

The distance between “CRM proved vertical cloud software could scale” and “Public-benefit status formalised a long-term operating philosophy” captures the larger story: Veeva Systems kept extending the value of its original expertise into new products, markets or infrastructure.

For TechnologyBlog.co.za, this page is intended to serve as the company-history cornerstone for future Veeva Systems coverage, so product and company-news articles can link back to one factual brand background instead of repeating the full origin story.

Primary sources checked include Veeva corporate, founder and public-benefit materials. Information reflects public material available on 18 September 2026. Official company identity cross-checked against http://www.veeva.com.